Suvretta Capital Management, LLC 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:47 pm Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | Suvretta Capital Management, LLC | 237,227 5.500% | 13,942 (+6.24%) | Filing |
| 2021-10-15 4:49 pm Purchase | 2021-10-05 | 13G | Gemini Therapeutics, Inc. GMTX | Suvretta Capital Management, LLC | 223,284 5.200% | 223,284 (New Position) | Filing |